JFL Life Sciences Limited (NSE:JFLLIFE)

India · Delayed Price · Currency is INR

10.85

0.00 (0.00%)

At close: Oct 16, 2026

Market Cap	358.00M -13.2%
Revenue (ttm)	1.31B +55.7%
Net Income	67.69M +126.3%
EPS	2.05 +162.5%
Shares Out	33.00M
PE Ratio	5.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,000
Open	11.10
Previous Close	10.85
Day's Range	10.35 - 11.35
52-Week Range	8.55 - 15.40
Beta	-0.27
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About JFL Life Sciences

JFL Life Sciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers beta lactam dry powder injections, beta lactam tablets and capsules, oral rehydration solutions, and general tablets and capsules. It also exports its products to Africa, the Middle East, Ukraine, Uzbekistan, and Kazakhstan. JFL Life Sciences Limited was incorporated in 2010 and is headquartered in Ahmedabad, India. [Read more]

Industry Pharmaceutical Preparations

Founded 2010

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol JFLLIFE

Full Company Profile

Financial Performance

In fiscal year 2026, JFL Life Sciences's revenue was 1.31 billion, an increase of 60.15% compared to the previous year's 820.42 million. Earnings were 64.01 million, an increase of 53.96%.

Financial Statements